Outpatient cancer clinics received a 3-month reprieve before Medicare institutes its new prospective payment system, which is expected to result in a big drop in reimbursement for some newer cancer drugs.
Outpatient cancer clinics received a 3-month reprievebefore Medicare institutes its new prospective payment system, which is expectedto result in a big drop in reimbursement for some newer cancer drugs.
TheCenters for Medicare & Medicaid Services (CMS) expected the new rates tobecome effective on January 1, 2002. The Association of Community Cancer Centershad been pressing for the delay and for a revamping of the formula Medicare usedto determine new payments for some cancer drugs.
Oncology Peer Review On-The-Go: Cancer Care Management During the COVID-19 Pandemic
October 28th 2020The newest episode of Oncology Peer Review On-The-Go speaks with 2 authors of an article from the October Issue of the journal ONCOLOGY focusing on effective cancer care management during the coronavirus pandemic.